NKTR
Nektar TherapeuticsCompany with tickers: NKTR
CIK
906709
CUSIP
640268306
Shares Outstanding
33,786,032
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $10,861,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $35,680,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Operating Income | $-39,054,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-44,904,000 | USD | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $-1.82 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $-1.82 | USD/shares | 2026-03-31 | 10-Q | 2026-05-08 |